Sample Donation Request Letter

Writing a Sample Donation Request Letter That Actually Gets Responses

A sample donation request letter is a formal document used by research institutions, hospitals, and labs to ask individuals or organizations to donate biological specimens—blood, tissue, swabs, urine, whatever the study requires. It sounds straightforward, but most drafts I see are either too clinical or too emotional, and neither approach works well in practice. The core problem is simple: you need informed consent, you need to communicate risk honestly, and you need to make it easy for the person to say yes without feeling manipulated. Every component matters because regulatory bodies and institutional review boards will tear apart a sloppy one.

Sample Donation Request Letter Format and Structure

Here is how I structure mine when I need to request samples from participants. This format has worked across multiple IRB approvals and reduced my back-and-forth with compliance teams significantly. Header and identification section: Include your institution's name, address, IRB approval number, and the principal investigator's contact information at the top. This is not optional if you want the letter to be taken seriously. People check for this first, and its absence signals amateur work immediately. Purpose statement: State clearly what the study is about in plain language. Avoid jargon. If you cannot explain the study's goal in two sentences, you do not understand it well enough to ask someone to donate to it.

What is being donated: Specify the sample type, volume, collection method, and frequency. "One 10ml blood draw" is clearer than "a small blood sample." The difference matters when someone is deciding whether to show up. Risk disclosure: List every possible side effect, however minor. Bruising, dizziness, soreness—write them all down. I learned this the hard way after a participant filed a complaint because I only mentioned "minor discomfort" instead of listing the actual possibilities. That complaint delayed our study by three weeks while we rewrote the letter. Benefits and compensation: Be honest about what the participant gains. If there is no direct benefit, say so. If they receive travel reimbursement or a small stipend, state the exact amount. Vague promises like "you will help science" do not satisfy IRBs or cautious donors.

Voluntary participation and withdrawal: Make it clear that saying no carries no penalty and that they can leave the study at any time. This is a legal requirement in most jurisdictions, not a courtesy. Privacy and data handling: Explain how their information will be stored, who will have access, and how long it will be kept. GDPR and HIPAA compliance should shape this section entirely. I once had a letter returned by our compliance office because I wrote "data may be shared with collaborators" instead of naming the specific institutions. That was on me. Signature lines: Include spaces for the participant's signature, date, and a witness signature if required by your local regulations. Also include a line for the collector's name and credentials.

Common Mistakes That Kill Response Rates

The biggest mistake I see is writing the letter for the IRB instead of the participant. These are different audiences. The IRB wants legal coverage. The participant wants to know whether showing up is worth their time. If your letter reads like a compliance checklist, people will skim past it. Another frequent error is burying the collection logistics. How long does the appointment take? Where does it happen? Do they need to fast beforehand? These details should appear early, not in a footnote. I adjusted my format to put the logistical questions within the first third of the letter, and our response rate increased by roughly 40 percent over six months. Some researchers also fail to specify what happens to the sample after donation. Will it be used for future research? Will it be destroyed? Can the participant request destruction? If you do not answer this, your IRB will ask about it, and the donor will definitely ask about it.

When a Standard Template Fails

Not every donation request fits a single template. I ran into this issue when requesting corneal tissue donations from eye banks. The standard blood draw letter was completely inadequate. We needed to address surgical retrieval, time sensitivity, and the fact that the "donor" was deceased, which raised ethical and consent issues that a living participant form does not cover. The workaround was to create a separate addendum that addressed organ and tissue-specific consent requirements, including next-of-kin authorization language and organ procurement organization contact information. Each sample type has its own regulatory nuance, and pretending one letter covers everything usually means covering nothing adequately.

Downloadable Template Reference

I keep a working Sample Donation Request Letter template that I use as a starting point for new studies. It includes all the sections described above with bracketed placeholders for study-specific information. You can adapt it to your needs, but do not skip the risk disclosure or privacy sections—those are where most compliance reviews get stuck. This format works well for routine biospecimen collection under approved IRB protocols. It does not work for emergency research without prospective consent, international multi-site studies with conflicting privacy laws, or situations involving vulnerable populations where additional safeguards are required. For those cases, you need legal counsel and a custom document, not a template. The biggest bottleneck I encounter is getting IRB approval on revised letters. Even small wording changes can trigger a full re-review depending on your institution's process. This usually adds two to four weeks to your timeline. Building in buffer time for revision cycles is something I wish I had factored into my initial study design much earlier.